+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oligonucleotide"

From
From
From
From
RNAi Drug Delivery: Technologies and Global Markets - Product Thumbnail Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • August 2023
  • 141 Pages
  • Global
From
Technology Growth Opportunities for Exosome-Mediated Drug Delivery - Product Thumbnail Image

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

  • Report
  • September 2022
  • 62 Pages
  • Global
From
RNA Therapeutics Growth Opportunities - Product Thumbnail Image

RNA Therapeutics Growth Opportunities

  • Report
  • May 2022
  • 51 Pages
  • Global
From
Technological Advances in RNA Stabilization & Delivery - Product Thumbnail Image

Technological Advances in RNA Stabilization & Delivery

  • Report
  • November 2021
  • 73 Pages
  • Global
From
Loading Indicator

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing. The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development. Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more